Inpatient treatment of severe disruptive behaviour disorders with risperidone and milieu therapy

Canadian Journal of Psychiatry

Volumn 45, Issue 4, 2000, Pages 376-382

  Ad Dab'bagh, Yasser ^a   Greenfield, Brian ^b   Milne Smith, Jennifer ^b   Freedman, Hyman ^b  

^a MCGILL UNIVERSITY   (Canada)

^b MONTREAL CHILDREN S HOSPITAL   (Canada)

Author keywords

Borderline disorders; Children; Disruptive behaviour disorders; Milieu therapy; Multiple complex developmental disorder; Risperidone

Indexed keywords

RISPERIDONE;

ADOLESCENT; ARTICLE; BEHAVIOR DISORDER; BORDERLINE STATE; CHILD; CHILD PSYCHIATRY; CLINICAL ARTICLE; DRUG EFFICACY; FEMALE; HUMAN; LEARNING DISORDER; MALE; PERSONALITY DISORDER; STATISTICAL ANALYSIS;

EID: 0034084109     PISSN: 07067437     EISSN: None     Source Type: Journal    
DOI: 10.1177/070674370004500407     Document Type: Article

References (22)

1. Leysen JE, Gommeren W, Eens A, de Chaffoy de Courcelles D, Stoof JC, Janssen PA. Biochemical profile of risperidone, a new antipsychotic. J Pharmacol Exp Ther 1988;247:661-70.
2. Czobor P, Voklava D, Meiback R. Effects of risperidone on hostility in schizophrenia. J Clin Psychopharmacol 1995;15:243-9
3. Purdon SE, Lit W, Labelle A, Jones BD. Risperidone in the treatment of pervasive developmental disorder. Can J Psychiatry 1994;39:400-5.
4. McDougle CJ, Brodkin ES, Yeung PP, Naylor ST, Cohen DJ, Price LH. Risperidone in adults with autism or pervasive developmental disorder. J Child Adolesc Psychopharmacol 1995;5:273-82.
5. Khan BU. Risperidone for severely disturbed behavior and tardive dyskinesia in developmentally disabled adults. J Autism Dev Disord 1997;27:479-89.
6. Vanden Borre R, Vermote R, Buttiens M, Thiry P, Dierick G, Geutjens J, and others. Risperidone as add-on therapy in behavioral disturbances in mental retardation: a double-blind placebo-controlled cross-over study. Acta Psychiatr Scand 1993;87:167-71.
7. Spencer T, Wilens T, Biederman J. Psychotropic medication for children and adolescents. Child Adolesc Psychiatr Clin North Am 1995;4:97-121.
8. Harden A, Johnson K, Johnson C, Hrecznyj B. Case study: risperidone treatment of children and adolescents with developmental disorders. J Am Acad Child Adolesc Psychiatry 1996;35:1551-6.
9. Demb H. Risperidone: maybe this shouldn't be the last resort. In: Antanitus D, editor. Success stories in developmental disabilities. Volume 4. Waltham (MA): Liberty Healthcare Corporation; 1995. p 11-4.
10. Demb HB. Risperidone in young children with pervasive developmental disabilities [letter]. J Child Adolesc Psychopharmacol 1996;6:79-80.
11. Perry RI, Pataki CS, Munoz DM, Armenteros JL, Silva RR. Pilot trial of risperidone in children and adolescents with pervasive developmental disorder. In: Proceedings of the 149th Annual Meeting of the American Psychiatric Association, New York; 1996. p 129.
12. Sternlicht HC, Wells SR. Risperidone in childhood schizophrenia [letter]. J Am Acad Child Adolesc Psychiatry 1995;34:540.
13. Simeon JG, Carrey NJ, Wiggins DM, Milin RP, Hosendocus SN. Risperidone effects in treatment-resistant adolescents: preliminary case reports. J Child Adolesc Psychopharmacol 1995;5:69-79.
14. Fras I, Major LF. Clinical experience with risperidone [letter]. J Am Acad Child Adolesc Psychiatry 1995;34:833.
15. Lombroso PJ, Scahill L, King RA, Lynch KA, Chappell PB, Peterson BS, and others. Risperidone treatment of children and adolescents with chronic tic disorders: a preliminary report. J Am Acad Child Adolesc Psychiatry 1995;34:1147-52.
16. Bruun RD, Budman CI. Risperidone as a treatment for Tourette's syndrome. J Clin Psychiatry 1996;57:29-31.
17. Findling RL, Grcevich SJ, Lopez I, Schulz SC. Antipsychotic medications in children and adolescents. J Clin Psychiatry 1996;9(Suppl 57): 19-23.
18. Lewis R. Typical and atypical antipsychotics in adolescent schizophrenia: efficacy, tolerability, and differential sensitivity to extrapyramidal symptoms. Can J Psychiatry 1998;43:596-604.
19. American Psychiatric Association. Diagnostic and statistical manual ofmental disorders. 4th ed. Washington (DC): American Psychiatric Association; 1994.
20. Shaffer D, Gould MS, Brasic J, Ambrosini P, Fisher P, Bird H, and others. A children's global assessment scale (CGAS). Arch Gen Psychiatry 1983;40:1228-31.
21. Lincoln AJ, Bloom D, Katz M, Boksenbaum N. Neuropsychological and neurophysiological indices of auditory processing impairment in children with multiple complex developmental disorder. J Am Acad Child Adolesc Psychiatry 1998;37:100-2.
22. Towbin KE, Dykens EM, Pearson GS, Cohen DJ. Conceptualizing "borderline syndrome of childhood" and "childhood schizophrenia" as a developmental disorder. J Am Acad Child Adolesc Psychiatry 1993;32:775-82.